Free Trial

Pro-Dex (PDEX) Competitors

Pro-Dex logo
$49.98 +0.57 (+1.15%)
Closing price 04:00 PM Eastern
Extended Trading
$49.84 -0.14 (-0.28%)
As of 04:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PDEX vs. KIDS, TMCI, DCTH, CLPT, NPCE, NYXH, SMLR, ZIMV, NNOX, and TCMD

Should you be buying Pro-Dex stock or one of its competitors? The main competitors of Pro-Dex include OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), Delcath Systems (DCTH), ClearPoint Neuro (CLPT), NeuroPace (NPCE), Nyxoah (NYXH), Semler Scientific (SMLR), ZimVie (ZIMV), Nano-X Imaging (NNOX), and Tactile Systems Technology (TCMD). These companies are all part of the "medical equipment" industry.

Pro-Dex vs.

OrthoPediatrics (NASDAQ:KIDS) and Pro-Dex (NASDAQ:PDEX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, community ranking, dividends, profitability, media sentiment, valuation, institutional ownership, earnings and analyst recommendations.

Pro-Dex has lower revenue, but higher earnings than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OrthoPediatrics$204.73M2.94-$20.97M-$1.63-15.18
Pro-Dex$61.00M2.67$2.13M$2.0124.87

69.1% of OrthoPediatrics shares are owned by institutional investors. Comparatively, 15.3% of Pro-Dex shares are owned by institutional investors. 31.8% of OrthoPediatrics shares are owned by company insiders. Comparatively, 47.5% of Pro-Dex shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

OrthoPediatrics presently has a consensus price target of $37.25, suggesting a potential upside of 50.51%. Pro-Dex has a consensus price target of $52.00, suggesting a potential upside of 4.04%. Given OrthoPediatrics' higher possible upside, equities research analysts clearly believe OrthoPediatrics is more favorable than Pro-Dex.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OrthoPediatrics
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75
Pro-Dex
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, OrthoPediatrics and OrthoPediatrics both had 7 articles in the media. OrthoPediatrics' average media sentiment score of 0.68 beat Pro-Dex's score of 0.22 indicating that OrthoPediatrics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
OrthoPediatrics
2 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Pro-Dex
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Pro-Dex has a net margin of 11.06% compared to OrthoPediatrics' net margin of -15.00%. Pro-Dex's return on equity of 21.68% beat OrthoPediatrics' return on equity.

Company Net Margins Return on Equity Return on Assets
OrthoPediatrics-15.00% -5.78% -4.80%
Pro-Dex 11.06%21.68%12.40%

OrthoPediatrics received 158 more outperform votes than Pro-Dex when rated by MarketBeat users. Likewise, 64.40% of users gave OrthoPediatrics an outperform vote while only 61.75% of users gave Pro-Dex an outperform vote.

CompanyUnderperformOutperform
OrthoPediatricsOutperform Votes
313
64.40%
Underperform Votes
173
35.60%
Pro-DexOutperform Votes
155
61.75%
Underperform Votes
96
38.25%

OrthoPediatrics has a beta of 1.22, indicating that its stock price is 22% more volatile than the S&P 500. Comparatively, Pro-Dex has a beta of 0.68, indicating that its stock price is 32% less volatile than the S&P 500.

Summary

OrthoPediatrics beats Pro-Dex on 9 of the 17 factors compared between the two stocks.

Remove Ads
Get Pro-Dex News Delivered to You Automatically

Sign up to receive the latest news and ratings for PDEX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PDEX vs. The Competition

MetricPro-DexSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$162.99M$4.42B$5.65B$8.06B
Dividend YieldN/A32.64%4.56%4.02%
P/E Ratio24.8728.9324.6019.02
Price / Sales2.6749.22383.6393.16
Price / Cash34.8151.0838.1634.64
Price / Book5.126.146.944.34
Net Income$2.13M$67.64M$3.20B$247.06M
7 Day Performance1.90%-1.87%-2.30%-0.52%
1 Month Performance48.18%-0.29%3.06%-3.72%
1 Year Performance187.08%15.16%11.11%1.81%

Pro-Dex Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PDEX
Pro-Dex
1.3633 of 5 stars
$49.98
+1.2%
$52.00
+4.0%
+186.9%$162.99M$61.00M24.87140Insider Trade
Short Interest ↑
News Coverage
KIDS
OrthoPediatrics
4.2204 of 5 stars
$24.96
-0.5%
$37.25
+49.2%
-7.2%$606.20M$204.73M-20.29200Positive News
TMCI
Treace Medical Concepts
2.532 of 5 stars
$7.97
+0.3%
$10.14
+27.3%
-25.3%$499.07M$209.36M-8.05250Short Interest ↓
DCTH
Delcath Systems
3.2804 of 5 stars
$13.19
+4.8%
$22.75
+72.5%
+189.2%$440.59M$37.21M-9.7760Positive News
CLPT
ClearPoint Neuro
2.1893 of 5 stars
$13.60
+6.3%
$25.00
+83.8%
+90.5%$375.80M$31.39M-19.71110Positive News
NPCE
NeuroPace
2.1862 of 5 stars
$11.24
+5.1%
$15.20
+35.2%
-4.6%$365.97M$79.91M-11.24170Short Interest ↑
Gap Up
NYXH
Nyxoah
2.7484 of 5 stars
$10.41
-1.0%
$15.25
+46.5%
-33.4%$354.57M$4.52M-5.57110Analyst Forecast
Short Interest ↓
News Coverage
High Trading Volume
SMLR
Semler Scientific
3.6316 of 5 stars
$36.03
+4.9%
$71.00
+97.1%
+39.2%$345.78M$56.29M7.34120Positive News
ZIMV
ZimVie
2.2199 of 5 stars
$12.21
+1.4%
$23.00
+88.4%
-29.6%$337.94M$449.75M-0.932,700
NNOX
Nano-X Imaging
1.7484 of 5 stars
$5.83
+2.5%
$17.50
+200.2%
-38.7%$336.85M$10.68M-6.86190
TCMD
Tactile Systems Technology
3.3359 of 5 stars
$13.53
+2.8%
$18.00
+33.0%
-13.5%$319.11M$292.98M19.33980Positive News
Remove Ads

Related Companies and Tools


This page (NASDAQ:PDEX) was last updated on 3/27/2025 by MarketBeat.com Staff
From Our Partners